SubHero Banner
Text

Caplyta® (lumateperone) – New drug approval

December 23, 2019 - Intra-Cellular Therapies’ announced the FDA approval of Caplyta (lumateperone), an atypical antipsychotic indicated for the treatment of schizophrenia in adults.

Download PDF